Physician profile

Thomas H Spence

Pulmonary Disease · Saint Louis, MO

NPI 1447221379

$17,289.07

in general payments reported to CMS, 2019-2025

50 companies · $2,754 in 2025

The $2,754 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,703.74
Travel and Lodging$591.96
Consulting Fee$17.69

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $3,171.00 2019-2025 Trelegy Ellipta, Arexvy, Nucala
Astrazeneca Pharmaceuticals LP $2,407.94 2019-2025 Airsupra, Tezspire, Fasenra
Boehringer Ingelheim Pharmaceuticals, INC. $2,353.25 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Actelion Pharmaceuticals US, INC. $1,147.71 2019-2025 Uptravi, Opsumit, Opsynvi
Insmed, INC. $1,032.20 2019-2025 Arikayce, Brinsupri
Inspire Medical Systems, INC. $834.74 2024-2025 Inspire
Regeneron Healthcare Solutions, INC. $643.95 2019-2025 Dupixent
Grifols USA, LLC $612.44 2019-2025 Prolastin-C Liquid
Genzyme Corporation $587.12 2019-2025
Philips North America LLC $453.82 2019-2025 (8874) Incourage, Encore, Vest Therapy Und
Electromed, INC. $422.11 2019-2025 Smartvest
Amgen INC. $310.54 2022-2025 Tezspire, Tavneos
United Therapeutics Corporation $294.14 2019-2025 Tyvaso, Tyvaso
Merck Sharp & Dohme LLC $255.24 2019-2025 Zerbaxa, Winrevair, Keytruda
Harmony Biosciences LLC $232.88 2021-2025
Show all 50 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $220.20 2019-2022
Bayer Healthcare Pharmaceuticals INC. $208.77 2019-2023
Tactile Systems Technology INC $189.25 2024-2025 Flexitouch Plus, Entre Plus, Nimbl
Mylan Specialty L.P. $160.47 2019-2024 Yupelri
Sunovion Pharmaceuticals INC. $151.86 2019
Takeda Pharmaceuticals U.S.A., INC. $146.99 2020-2025 Glassia
Pfizer INC. $145.88 2019-2025
Advanced Respiratory, INC $118.26 2019-2021
Jazz Pharmaceuticals INC. $109.09 2019-2022
Viatris Specialty LLC $83.78 2025 Yupelri
Axsome Therapeutics, INC. $81.92 2023-2024 Sunosi
Fisher & Paykel Healthcare INC $81.15 2020-2025 Fisher & Paykel Healthcare
Abbvie INC. $72.71 2024-2025
Baxter Healthcare $66.27 2023-2025 Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care
Novartis Pharmaceuticals Corporation $62.04 2019-2023
Ani Pharmaceuticals, INC. $60.35 2024 Purified Cortrophin Gel
Circassia INC. $60.33 2019
Janssen Pharmaceuticals, INC $56.86 2020-2022
Verona Pharma, INC. $56.61 2025 Ohtuvayre
Lilly USA, LLC $43.69 2025 Zepbound
Gilead Sciences, INC. $42.28 2019
Ceribell, INC. $38.53 2024 Pocket Eeg Device
3b Medical, INC. $31.71 2024 Luna
Genentech USA, INC. $31.68 2019
Paratek Pharmaceuticals, INC. $27.85 2023 Nuzyra
Cumberland Pharmaceuticals, INC. $24.78 2019-2020
Itamar Medical INC $24.70 2025 Watchpatone
Sanofi-Aventis U.S. LLC $23.78 2021
Adma Biomanufacturing LLC $17.69 2025
Azurity Pharmaceuticals, INC. $17.63 2025 Alvesco
Shire North American Group INC $15.36 2019
Pulmonx Corporation $14.62 2023 Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve
Apria Healthcare LLC $14.46 2021
Resmed Corp $14.34 2019
Inari Medical, INC. $14.10 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas H Spence

$17,289.07

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $2,754 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/247257/thomas-h-spence

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.